# Shenogen Pharma Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenogen-pharma-group

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.shenogen.com.cn
- Total disclosed funding: $61M
- Latest round: Series F (Jul 20, 2017)
- Investors on record: 12

## About

Established in 2006 and based in Beijing, China, Shenogen Pharma Group is a drug discovery and development company. The firm primarily focuses on the development of therapeutics for cancer treatment.

## Funding rounds

- Series F, Jul 20, 2017, $45M — Panlin Capital, Sunshare Capital Management, Harlyn Capital
- Series E, Jun 17, 2016 — Panlin Capital
- Series D, Nov 30, 2015 — Panlin Capital
- Series C, Jun 1, 2015, $2.1M — Qiming Venture Partners
- Series B, Sep 1, 2013, $5M — Qiming Venture Partners
- Series A, Apr 8, 2011, $8.4M — RCI Capital Group Inc., IDG Capital, Oriza Holdings, Reiter Capital, Lotus Lake Capital, Beijing Zhonghai Jinyue Investment Management, Lapam Capital
- Angel, Mar 20, 2010 — Legend Capital

## Investors

- Legend Capital — Angel
- RCI Capital Group Inc. — Series A
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A
- Reiter Capital (https://capitalatlas.ai/funds/reiter-capital) — Series A
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A
- Beijing Zhonghai Jinyue Investment Management (https://capitalatlas.ai/funds/beijing-zhonghai-jinyue-investment-management) — Series A
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B, Series C
- Panlin Capital (https://capitalatlas.ai/funds/panlin-capital) — Series D, Series E, Series F
- Sunshare Capital Management (https://capitalatlas.ai/funds/sunshare-capital-management) — Series F
- Harlyn Capital (https://capitalatlas.ai/funds/harlyn-capital) — Series F